Tirzepatide 20mg – Research Peptide
Structure, Molecular Mechanism of Action, Receptor Interactions: Tirzepatide is a first-in-class, unimolecular, long-acting dual GIP/GLP-1 receptor agonist (39-amino acid syntheticlinear peptide.
Tirzepatide is a dual incretin receptor agonist studied for its effects on metabolic signaling and energy regulation pathways. In research models, it is examined for its interaction with glucose balance, appetite-related signaling, and hormonal coordination.
Molecular Mechanism of Action : Tirzepatide is a dual agonist of the glucose-dependent
insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R),
both class B GPCRs. Tirzepatide exhibits imbalanced agonism (preferential GIPR engagement) and biased signaling at GLP-1R, driving its superior glycemic/weight effects vs. GLP-1R mono-agonists.
- GIPR: Unbiased; full mimicry of GIP (Gs → ↑cAMP → PKA; β-arrestin2;
internalization).
- GLP-1R: Biased partial agonist favoring Gs/cAMP
Downstream Molecular/Physiologic Effects (Glucose-Dependent):
- Pancreatic β-cells (both receptors): Gs–cAMP–PKA → voltage-gated Ca²⁺
influx/exocytosis → insulin secretion; improved β-cell function/sensitivity.
- α-cells (GLP-1R dominant): Glucagon suppression.
- GI (GLP-1R): Delayed gastric emptying; satiety/appetite reduction (central
hypothalamic arcuate/paraventricular neurons).
- Adipose/liver/muscle (GIPR + GLP-1R): Enhanced insulin sensitivity, lipid buffering
(↑adiponectin), reduced ectopic fat, improved metabolic flexibility.
- CNS: Reduced food intake/energy intake; sustained signaling from bias may enhance weight loss durability. Net: Superior HbA1c reduction (1.6–2.4%), weight loss (15–21% at 72 wk), cardiometabolic benefits (lipids, BP) vs. GLP-1 mono-agonists.
Want to understand the receptor signaling behind this compound?
→ What is Tirzepatide? Dual GLP-1/GIP Peptide Explained
Explore how dual-receptor incretin signaling compares with next-generation triple agonists.
→ Retatrutide vs Tirzepatide: Mechanism Comparison
Tirzepatide is commonly examined in research involving incretin signaling and metabolic regulation. For a broader perspective on how injectable peptides compare with oral compounds:
→ Oral vs Injectable Compounds (Orforglipron, Tirzepatide, Retatrutide)
To explore how incretin-based signaling pathways interact with muscle metabolism and adaptive physiology in research models, see:
→ Muscle Preservation During GLP-1/GIP Therapy
Product description:
- Molecular Formula: C225H348N48O68
-
Molecular Weight: 4813 g/m
- CAS: 2023788-19-2
-
Total Active Ingredient: 20 mg per vial - ( Vial format: lyophilized powder for enhanced stability.)
Structures:

Product Usage
In vitro research or further manufacturing use only. Not for human or animal use.
Peptide Storage
All information provided by PRG is for educational and informational purposes only.
Best Practices for Storing Peptides
To maintain the reliability of laboratory results, correct peptide storage is essential. Proper storage conditions help preserve peptide stability for years while protecting against contamination, oxidation, and breakdown. Although certain peptides are more sensitive than others, following these best practices will greatly extend their shelf life and structural integrity.
- Short-Term Storage (days to months): Keep peptides cool and protected from light. Temperatures below 4 °C (39 °F) are generally suitable. Lyophilized peptides often remain stable at room temperature for several weeks, but refrigeration is still preferred if use is not immediate.
- Long-Term Storage (months to years): Store peptides at –80 °C (–112 °F) for maximum stability. Avoid frost-free freezers, as defrost cycles can cause damaging temperature fluctuations.
- Minimize Freeze–Thaw Cycles: Repeated freezing and thawing accelerates degradation. Instead, divide peptides into aliquots before freezing.
Preventing Oxidation & Moisture Damage
Peptides can be compromised by exposure to moisture and air—especially immediately after removal from a freezer.
- Let the vial warm to room temperature before opening to prevent condensation.
- Keep containers sealed as much as possible, and if possible, reseal under a dry, inert gas such as nitrogen or argon.
- Amino acids like cysteine (C), methionine (M), and tryptophan (W) are particularly sensitive to oxidation.
Storing Peptides in Solution
Peptides in solution have a much shorter lifespan compared to lyophilized form and are prone to bacterial degradation.
- If storage in solution is unavoidable, use sterile buffers at pH 5–6.
- Prepare single-use aliquots to avoid repeated freeze–thaw cycles.
- Most peptide solutions are stable for up to 30 days at 4 °C (39 °F), but sensitive sequences should remain frozen when not in use.
Containers for Peptide Storage
Select containers that are clean, intact, chemically resistant, and appropriately sized for the sample.
- Glass vials: offer clarity, durability, and chemical resistance.
- Plastic vials: polystyrene (clear but less resistant) or polypropylene (translucent but chemically resistant).
- Peptides shipped in plastic vials may be transferred to glass for long-term storage if desired.
Regenesis Peptide Storage Quick Tips
- Keep peptides in a cold, dry, dark environment
- Avoid repeated freeze–thaw cycles
- Minimize exposure to air
- Protect from light
- Avoid storing in solution long term
- Aliquot peptides to match experimental needs